Belfast, United Kingdom

Martin O'Rourke

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The Queen's University of Belfast. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin O'Rourke. Retrieved from https://idiyas.com/inventor/martin-o-rourke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Carrickfergus, GB (2011)
  • Belfast, GB (2012 - 2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Martin O'Rourke: Innovator in Peptide Research

Introduction

Martin O'Rourke is a distinguished inventor based in Belfast, GB. He has made significant contributions to the field of peptide research, holding a total of 3 patents. His work focuses on the development of innovative peptides that have potential applications in treating cardiovascular diseases.

Latest Patents

O'Rourke's latest patents include a notable invention titled "Peptides, compositions and uses thereof." This patent describes an N-terminal hexapeptide fragment of maximakinin, known as QUB 698.8. This fragment exhibits potent tissue-selective actions on smooth muscle. It demonstrates a high degree of selectivity for arterial smooth muscle over small intestinal smooth muscle, causing potent relaxation of arterial smooth muscle while inducing less potent contraction of ileal smooth muscle. This innovation may be utilized in the treatment of diseases of the cardiovascular system and in the promotion of angiogenesis.

Career Highlights

Martin O'Rourke is affiliated with The Queen's University of Belfast, where he conducts his research. His work has garnered attention for its potential impact on medical treatments and therapeutic applications.

Collaborations

O'Rourke collaborates with esteemed colleagues, including David Hirst and Tianbao Chen, who contribute to his research endeavors.

Conclusion

Martin O'Rourke's innovative work in peptide research highlights his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…